AI Image
FDA recalls thousands of blood pressure bottles after it failed quality tests
WMUR • • health
Key Points:
- The U.S. FDA has issued a nationwide recall of certain blood pressure medications produced by Macleods Pharma USA due to quality concerns.
- The recall affects specific lots of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide tablets, with a total of 3,744 bottles recalled.
- The recall was initially announced on October 7, 2026, and later classified as Class II on October 26, 2026, indicating potential temporary or reversible health risks.
- The recalled medication failed quality tests because the pills did not dissolve properly, compromising their effectiveness.
- Consumers are advised to check their medicine cabinets and avoid using the affected lots, which expire on May 31, 2027.
